Letters

Monitoring the frequency of side effects of drugs

BMJ 1996; 312 doi: http://dx.doi.org/10.1136/bmj.312.7043.1418c (Published 01 June 1996) Cite this as: BMJ 1996;312:1418

Reasons for stopping drugs could be recorded in general practice

  1. Richard Martin,
  2. Sean Hilton,
  3. Nicky Richards
  1. Prescribing research fellow Professor Department of General Practice and Primary Care, St George's Hospital Medical School, London SW17 0RE
  2. Research scientist Doctors Independent Network, 1 Tannery House, Tannery Lane, Send, Woking, Surrey GU23 7HA

    EDITOR,—R Bracchi highlights the need for general practitioners to have more information on the frequency of adverse drug events.1 Premarketing trials, which are limited by their small size, short duration, narrow set of indications, and exclusion criteria, provide some data but may not accurately reflect clinical practice.2 Spontaneous reporting after marketing (the yellow card scheme) is an essential early warning system, but many adverse drug events remain unreported, one of the reasons being lack of confidence in diagnosing an adverse reaction.3 We …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe